Nanotechnology Video Lectures & Seminars

 

 

 

NIH Video Casting

 

NCI Nanotechnology Video Seminars

 

Click Here to Play Video.  This video is world accessible. Abraxane: Nanoparticle Platform Delivers Improved Antitumor Activity
Tuesday, January 24, 2006
Michael Hawkins, M.D., American Bioscience
Total Running Time: 00:56:40
more information
Click Here to Play Video.  This video is world accessible. Anticancer Nanomedicines: Current Status and Future Opportunities
Tuesday, September 27, 2005
Ruth Duncan, Ph.D., Cardiff University, Wales, United Kingdom
Total Running Time: 01:12:46
more information
Click Here to Play Video.  This video is world accessible. The Bio Bar Code Assay: Changing The Playing Field In Cancer Diagnostics
Tuesday, April 26, 2005
Chad A. Mirkin Ph.D., Northwestern University
Total Running Time: 01:15:52
more information
Click Here to Play Video.  This video is world accessible. Nano Systems Biology and Cancer
Tuesday, March 08, 2005
James R. Heath, Ph.D., California Institute of Technology
Total Running Time: 00:56:09
more information
Click Here to Play Video.  This video is world accessible. Novel Drug Delivery Systems for Cancer
Thursday, February 24, 2005
Robert S. Langer, Ph.D., Massachusetts Institute of Technology
Total Running Time: 01:00:23
more information
Click Here to Play Video.  This video is world accessible. Tumor Targeting Nanodelivery Systems: Expanding Potential for Cancer Therapy and Diagnosis
Thursday, January 27, 2005
Esther H. Chang, Ph.D., Georgetown University Medical Center
Total Running Time: 01:03:07
more information
Click Here to Play Video.  This video is world accessible. NCI Alliance for Nanotechnology in Cancer PreApplication Meeting
Tuesday, December 14, 2004
NCI
Total Running Time: 04:56:39
more information

 

MIT World

 

Nanotechnology and the Study of Human Diseases (June 10, 2006)

 

Subra Suresh fleshes out the promise of nanotechnology, at least in regard to our understanding of disease. His talk, which focuses on malaria and its impact on red blood cells, demonstrates how the fields of engineering, biology and medicine are converging.